SODIUM SULFACETAMIDE, SULFUR

Manufacturer
Westminster Pharmaceuticals, LLC
Effective date
2025-07-01
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
6
Source
full-release
Hydrated at
2026-05-31 21:37:17

Label at a glance#

ProductSODIUM SULFACETAMIDE, SULFUR
Active ingredientSULFACETAMIDE SODIUM, SULFUR
Label structure13 sections

Dosage and administration

Apply Sodium Sulfacetamide 10% and Sulfur 5% Cleanser once or twice daily to affected areas, or as directed by your physician. Wet skin and liberally apply to areas to be cleansed. Massage gently into skin for 10-20 seconds, working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing off Sodium Sulfacetamide 10% and Sulfur 5% Cleanser sooner or using less often.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx Only

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

DESCRIPTION

DESCRIPTION SECTION

Each gram of Sodium Sulfacetamide 10% and Sulfur 5% Cleanser contains 100 mg of sodium sulfacetamide and 50 mg of sulfur in a formulation containing Aloe Vera Leaf Extract, Butylated Hydroxytoluene, Cetyl Alcohol, Citric Acid, Cocamidopropyl Betaine, Disodium EDTA, Glycerin, Glyceryl Stearate SE, PEG-100 Stearate, Phenoxyethanol, Purified Water, Sodium Laureth Sulfate, Sodium Thiosulfate, Stearyl Alcohol, Triacetin, Xanthan Gum.

Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically sodium sulfacetamide is N-[(4-aminophenyl) sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is:

Chemical Structure
Chemical Structure

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

The most widely accepted mechanism of action of sulfonamides is the Woods-Fildes theory, which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, sodium sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological half-life has variously been reported as 7 to 12.8 hours. The exact mode of action of sulfur in the treatment of acne is known, but it has been reported that it inhibits the growth of Propionibacterium acnes and the formation of free fatty acids.

INDICATIONS

INDICATIONS & USAGE SECTION

Sodium Sulfacetamide 10% and Sulfur 5% Cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Sodium Sulfacetamide 10% and Sulfur 5% Cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. Sodium Sulfacetamide 10% and Sulfur 5% Cleanser is not to be used by patients with kidney disease.

WARNINGS

WARNINGS SECTION

Although rare, sensitivity to sodium sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice, and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.

FOR EXTERNAL USE ONLY. Keep away from eyes. keep out of reach of children. In case of accidental ingestion contact a poison control center immediately. Keep container tightly closed.

PRECAUTIONS

PRECAUTIONS SECTION

General

GENERAL PRECAUTIONS SECTION

If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. The object of this therapy is to achieve desquamation without irritation, but sodium sulfacetamide and sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility.

Information for Patients

INFORMATION FOR PATIENTS SECTION

Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. If excessive irritation develops, discontinue use and consult your physician.

Carcinogenesis, Mutagenesis and Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Long-term studies in animals have not been performed to evaluate carcinogenic potential.

Pregnancy

PREGNANCY SECTION

Category C

TERATOGENIC EFFECTS SECTION

Animal reproduction studies have not been conducted with Sodium Sulfacetamide 10% and Sulfur 5% Cleanser. It is also not known whether Sodium Sulfacetamide 10% and Sulfur 5% Cleanser can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sodium Sulfacetamide 10% and Sulfur 5% Cleanser should be given to a pregnant woman only if clearly needed.

Nursing Mothers

NURSING MOTHERS SECTION

It is not known whether sodium sulfacetamide is excreted in the human milk following topical use of Sodium Sulfacetamide 10% and Sulfur 5% Cleanser. However, small amounts of orally administered sulfonamides have been reported to be eliminated in human milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when Sodium Sulfacetamide 10% and Sulfur 5% Cleanser is administered to a nursing woman.

Pediatric Use

PEDIATRIC USE SECTION

Safety and effectiveness in children under the age of 12 have not been established.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Although rare, sodium sulfacetamide may cause local irritation.

Call your doctor for medical advice about side effects. To report a serious adverse event, please contact Westminster Pharmaceuticals at 1-844-221-7294

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Apply Sodium Sulfacetamide 10% and Sulfur 5% Cleanser once or twice daily to affected areas, or as directed by your physician. Wet skin and liberally apply to areas to be cleansed. Massage gently into skin for 10-20 seconds, working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing off Sodium Sulfacetamide 10% and Sulfur 5% Cleanser sooner or using less often.

HOW SUPPLIED

HOW SUPPLIED SECTION

Sodium Sulfacetamide 10% and Sulfur 5% Cleanser is available in 6 oz. (170.3 g) bottles, NDC 69367-247-06, 8 oz. (227 g), NDC 69367-247-08, and 12 oz. (340.2 g) bottles, NDC 69367-247-12.

STORAGE AND HANDLING SECTION

Store at 15°C to 30°C (59°F to 86°F). Protect from freezing.

SPL UNCLASSIFIED SECTION

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN

All prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable. NOTE: This is not an Orange Book product. No representation is made as to generic status or bioequivalency. Each person recommending a prescription substitution using this product shall make such recommendations based on each such person's professional opinion and knowledge, upon evaluating the active ingredients, excipients, inactive ingredients and chemical formulation information provided herein.

SPL UNCLASSIFIED SECTION

Manufactured for:
Westminster Pharmaceuticals, LLC
Nashville, TN 37217

Rev. 06/25

PRINCIPAL DISPLAY PANEL - 170.3 g Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 69367-247-06
Rx Only

Sodium
Sulfacetamide 10%
and Sulfur 5%
Cleanser

FOR EXTERNAL USE ONLY

6 oz (170.3 g)

Westminster
Pharmaceuticals

PRINCIPAL DISPLAY PANEL - 170.3 g Bottle Label
PRINCIPAL DISPLAY PANEL - 170.3 g Bottle Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
999613sulfacetamide sodium 10 % / sulfur 5 % Medicated Liquid SoapPSN6
999613sulfacetamide sodium 100 MG/ML / sulfur 50 MG/ML Medicated Liquid SoapSCD6
999613sulfacetamide sodium 10 % / sulfur 5 % Medicated Liquid SoapSY6
999613sulfacetamide sodium 10 % / sulfur 5 % Topical CleanserSY6

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
SULFACETAMIDE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4073022c-5d5d-48f5-82ed-091ad146a4b2Product name120171211
9ffbd0ae-0bce-c086-b707-f0da5f8cd7c5Product name120150828
0304b7d2-7a07-d53b-750f-36012ae6612eProduct name120140508
64c0cc7e-6478-3ca1-8cd7-9a1251d5a3f6Product name120140508
9ae74339-0a3d-82e9-5dd1-88bd2607bd6bProduct name120140508
e44e38a9-2d9e-b0e2-cce9-490554639f3dProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69367-247-062024-01-30C16284748780-11030e365-09dd-111a-e063-dadaa90a10e2Sodium Sulfacetamide 10% and Sulfur 5% Cleanser
69367-247-122024-01-30C16284748780-11030e365-09dd-111a-e063-dadaa90a10e2Sodium Sulfacetamide 10% and Sulfur 5% Cleanser

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69367-247-06SODIUM SULFACETAMIDE, SULFUR170.3 g in 1 BOTTLELIQUID170.36
69367-247-08SODIUM SULFACETAMIDE, SULFUR227 g in 1 BOTTLELIQUID2276
69367-247-12SODIUM SULFACETAMIDE, SULFUR340.2 g in 1 BOTTLELIQUID340.26

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
69367-247-06GM - Gram69367-2471ce0c10e-d0c7-42fb-9bc3-7c36b860527212020-07-13
69367-247-08GM - Gram69367-24777114718-c684-403a-a66c-ca876984490712025-08-11
69367-247-12GM - Gram69367-247e5c200f3-676e-4969-acce-209f7d8c8ef012020-07-13

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69367-24769367-247-06, 69367-247-12, 69367-247-08

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SODIUM SULFACETAMIDE, SULFURSULFACETAMIDE SODIUM AND SULFURWestminster Pharmaceuticals, LLC6b7e2859-d149-4116-bd98-d6d096266b042025-07-01Warnings, Adverse reactionsExact identifier
ndc (package): 69367-247-12
ndc (package): 69367-247-06
ndc (package): 69367-247-08
ndc (product): 69367-247
ndc11 (package): 69367024712
ndc11 (package): 69367024708
ndc11 (package): 69367024706
spl id: 33621d74-84ee-4831-8935-95cd618398fc
spl set id: 6b7e2859-d149-4116-bd98-d6d096266b04

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.